Key facts
- Notable investors include Shenzhen Bangqin Venture Capital Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ronghui Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Ronghui Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ronghui Pharmaceutical
Manufacturer and distributor of medical devices and pharmaceutical products designed to support healthcare institutions and medical supply chains. The company engages in the research, production, and sales of medical devices, along with pharmaceutical wholesale, food sales, Class I and Class II medical device distribution, and business management consulting services, providing integrated healthcare product and operational support solutions.
- Sector
- Healthcare
- HQ
- Zhengzhou, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Ronghui Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ronghui Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ronghui Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.